Evaluating the safety and efficacy of eluxadoline for treating diarrhea-predominant irritable bowel syndrome: A Meta-analysis

Shah E.; Schoenfeld P.

首页> 外文期刊>Neurogastroenterology and motility >Evaluating the safety and efficacy of eluxadoline for treating diarrhea-predominant irritable bowel syndrome: A Meta-analysis

【24h】

Evaluating the safety and efficacy of eluxadoline for treating diarrhea-predominant irritable bowel syndrome: A Meta-analysis

机译：评估依拉西多林治疗腹泻型肠易激综合征的安全性和有效性：一项荟萃分析

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Neurogastroenterology and motility 》 |2016年第1期| 共1页
作者
Shah E.; Schoenfeld P.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病 ;
关键词

相似文献

外文文献
中文文献
专利

1. Evaluating the safety and efficacy of eluxadoline for treating diarrhea-predominant irritable bowel syndrome: A Meta-analysis [J] . Shah E., Schoenfeld P. Neurogastroenterology and motility . 2016 ,第Suppla1期

机译：评估依拉西多林治疗腹泻型肠易激综合征的安全性和有效性：一项荟萃分析
2. Rifaximin and eluxadoline - newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron? [J] . Cash Brooks D., Lacy Brian E., Rao Tharaknath, Expert opinion on pharmacotherapy . 2016 ,第3期

机译：利福昔明和依法西林-新批准的腹泻型肠易激综合症治疗药物：与阿洛司琼一起在临床实践中起什么作用？
3. Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome [J] . Aleksandra Sobolewska-W?odarczyk, Marcin W?odarczyk, Martin Storr, Therapeutics and Clinical Risk Management . 2016 ,第1期

机译：依拉西多林治疗腹泻型肠易激综合征的临床潜力
4. The Effects of Wumei Pill on Intestinal Flora and Neurotransmitters in Rats with Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) [C] . Xiaojie Ding, Xiling Sun, Xiaofei Yu, International Conference on Biotechnology and Bioengineering . 2019

机译：尿布丸对腹泻的肠道菌群和神经递质的影响（IBS-D）
5. Irritable Bowel Syndrome and Vitamin D Insufficiency: The Effects of Vitamin D Level on Irritable Bowel Syndrome [D] . Pollock, Mary E. 2018

机译：肠易激综合征和维生素D功能：维生素D水平对肠易激综合征的影响
6. Efficacy and Safety of Acupoint Catgut Embedding for Diarrhea-Predominant Irritable Bowel Syndrome and Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis [O] . Jing Wu, Qinwei Fu, Shasha Yang, 2020

机译：对腹泻的疗效和安全性对腹泻的抗肠肠综合征和便秘 - 主要的肠易激综合征：系统审查和荟萃分析
7. Efficacy and Safety of Acupoint Catgut Embedding for Diarrhea-Predominant Irritable Bowel Syndrome and Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis [O] . Jing Wu, Qinwei Fu, Shasha Yang, 2020

机译：对腹泻的疗效和安全性对腹泻的抗肠肠综合征和便秘 - 主要的肠易激综合征：系统审查和荟萃分析

Evaluating the safety and efficacy of eluxadoline for treating diarrhea-predominant irritable bowel syndrome: A Meta-analysis

著录项

相似文献

相关主题

期刊订阅